Changes in Stockholders’ Equity |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in Stockholders’ Equity |
Note 15 – Changes in Stockholders’ Equity
Common Stock
The Company is authorized to issue an aggregate of shares of common stock with a par value of $ . As of June 30, 2024, there were shares of common stock issued and outstanding.
Common Stock Issued in Escrow Pursuant to Default Provisions of Debt Financing
On March 4, 2024, the Company issue shares of common stock in escrow pursuant to default provisions on deft financing received from the Sanguine Group. The shares were cancelled pursuant to the subsequent debt repayment on April 22, 2024.
Common Stock Issued as a Promissory Note Commitment
On April 19, 2024, the Company paid a commitment fee to AJB Capital in the form of 80,185, based on the closing price of the Company’s common stock on the date of grant and the fair value of the debt received. The shares are being amortized as a debt discount over the life of the loan. shares of common stock in connection with the issuance of the Fourth AJB Note (defined above). The relative fair value of the common stock was $
On March 19, 2024, the Company paid a commitment fee to Joerg Sommer, the Company’s President, in the form of 9,839, based on the closing price of the Company’s common stock on the date of grant and the fair value of the debt received. The shares are being amortized as a debt discount over the life of the loan. shares of common stock in connection with the issuance of the Second Sommer Note (defined above). The relative fair value of the common stock was $
On March 4, 2024, the Company paid a commitment fee to The Sanguine Group, LLC in the form of 73,454, based on the closing price of the Company’s common stock on the date of grant and the fair value of the debt received. The shares are being amortized as a debt discount over the life of the loan. shares of common stock in connection with the issuance of the First Sanguine Note (defined above). The relative fair value of the common stock was $
ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Common Stock Issued as Consideration for Related Party Debt Modifications
On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., agreed to issue shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing, as listed below. The aggregate fair value of the common stock was $724,086, based on the closing price of the Company’s common stock on the date of grant, which was recognized as a loss on early extinguishment of debt. The previously issued promissory notes were cancelled in exchange for promissory notes with a maturity date of March 1, 2027, bearing interest at 10% per annum, with the exception of the promissory note issued to Dr. John McCabe, which carries an interest rate of 7% per annum.
Common Stock Issued for Services, Related Parties
On June 15, 2023, the Company issued 89,850, based on the closing price of the Company’s common stock on the date of grant. The shares were expensed upon issuance. shares of common stock to the Company’s President, Joerg Sommer, for services provided. The aggregate fair value of the common stock was $
On March 15, 2024, the Company issued shares of common stock to officers and directors for services provided, as listed below. The aggregate fair value of the common stock was $429,000, based on the closing price of the Company’s common stock on the date of grant. The shares were expensed upon issuance.
Common Stock Issued for Services
On May 10, 2024, the Company issued The fair value of the shares was $76,250, based on the closing price of the Company’s common stock on the date of grant. shares of common stock in consideration of consulting services.
On March 31, 2024, the Company awarded 24,695, based on the closing price of the Company’s common stock on the date of grant. The shares were subsequently issued on May 10, 2024. shares of common stock to ClearThink Capital Partners, LLC, for services provided. The fair value of the common stock was $
On March 15, 2024, the Company issued an aggregate 33,000, based on the closing price of the Company’s common stock on the date of grant. The shares were expensed upon issuance. shares of common stock to two consultants for services provided. The aggregate fair value of the common stock was $
On February 9, 2024, the Company issued 5,386, based on the closing price of the Company’s common stock on the date of grant. shares of common stock to ClearThink Capital Partners, LLC, for services provided. The fair value of the common stock was $
Common Stock Subscriptions Payable Issued for Services
On June 30, 2024, the Company awarded 12,473, based on the closing price of the Company’s common stock on the date of grant. The shares were subsequently issued on August 7, 2024. shares of common stock to ClearThink Capital Partners, LLC, for services provided. The fair value of the common stock was $
ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Amortization of Stock-Based Compensation
A total of $7,704 and $73,338 of stock-based compensation expense was recognized from the amortization of options to purchase common stock over their vesting period during the six months ended June 30, 2024 and 2023, respectively.
|